Epidemiology and Risk Factors in Non-infectious Uveitis: A Systematic Review

被引:49
作者
Joltikov, Katherine A. [1 ]
Lobo-Chan, Ann-Marie [1 ]
机构
[1] Univ Illinois, Coll Med, Illinois Eye & Ear Infirm, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA
关键词
non-infectious uveitis; epidemiology; risk factors; systematic review; incidence; prevalence; VITAMIN-D LEVELS; ACUTE ANTERIOR UVEITIS; OCULAR ADVERSE EVENTS; PREVALENCE; ASSOCIATION; DISEASE; POPULATION; SMOKING; PREGNANCY; HEALTH;
D O I
10.3389/fmed.2021.695904
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Non-infectious uveitis is a leading cause of vision loss in the developed world. The purpose of this systematic review is to investigate the epidemiology and risk factors of non-infectious uveitis over the last 50 years. Methods: A systematic literature search of Pubmed/MEDLINE database was performed in the 50-year period from January 1971 to January 2021, according to the PRISMA guidelines. Studies that assessed the epidemiology and risk factors for non-infectious uveitis were included. Results: Few epidemiologic studies focus specifically on non-infectious uveitis. In the Unites States, the estimated prevalence of non-infectious uveitis is 121/100,000. The incidence and prevalence varies considerably worldwide. Females and the working age group (20-50 years) appear to be the most affected. Smoking and vitamin D deficiency are the biggest risk factors for non-infectious uveitis, while pregnancy appears to be protective. Additional risk factors include presence of other autoimmune diseases (thyroid disease, diabetes, celiac), pre-eclampsia/eclampsia, psychological stress, and certain medications (bisphosphonates, immune checkpoint inhibitors, female hormone therapy, and etanercept). Discussion: Our systematic review summarizes the incidence and prevalence of non-infectious uveitis and associated modifiable and non-modifiable risk factors.
引用
收藏
页数:16
相关论文
共 85 条
  • [11] Patterns of Vitamin D Levels and Exposures in Active and Inactive Noninfectious Uveitis Patients
    Chiu, Zelia K.
    Lim, Lyndell L.
    Rogers, Sophie L.
    Hall, Anthony J.
    [J]. OPHTHALMOLOGY, 2020, 127 (02) : 230 - 237
  • [12] Costa E, 2020, ACTA REUMATOL PORT, V45, P265
  • [13] Serum Vitamin D Levels in Patients with Acute Anterior Uveitis
    Dadaci, Zeynep
    Cetinkaya, Servet
    Acir, Nursen Oncel
    Oncel, Mufide
    Borazan, Mehmet
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2017, 25 (04) : 492 - 496
  • [14] Population based assessment of uveitis in an urban population in southern India
    Dandona, L
    Dandona, R
    John, RK
    McCarty, CA
    Rao, GN
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (07) : 706 - 709
  • [15] Acute stress enhances while chronic stress suppresses skin immunity - The role of stress hormones and leukocyte trafficking
    Dhabhar, FS
    [J]. NEUROIMMUNOMODULATION: PERSPECTIVES AT THE NEW MILLENNIUM, 2000, 917 : 876 - 893
  • [16] Degree, duration, and causes of visual loss in uveitis
    Durrani, OM
    Tehrani, NN
    Marr, JE
    Moradi, P
    Stavrou, P
    Murray, PI
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (09) : 1159 - 1162
  • [17] Risk for Uveitis With Oral Moxifloxacin A Comparative Safety Study
    Eadie, Brennan
    Etminan, Mahyar
    Mikelberg, Frederick S.
    [J]. JAMA OPHTHALMOLOGY, 2015, 133 (01) : 81 - 84
  • [18] Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
    Etminan, Mahyar
    Forooghian, Farzin
    Maberley, David
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2012, 184 (08) : E431 - E434
  • [19] Ocular adverse events with immune checkpoint inhibitors
    Fang, Tony
    Maberley, David A.
    Etminan, Mahyar
    [J]. JOURNAL OF CURRENT OPHTHALMOLOGY, 2019, 31 (03): : 319 - 322
  • [20] Uveitis Risk following Oral Fluoroquinolone Therapy: A Nested Case-control Study
    Forooghian, Farzin
    Maberley, David
    Albiani, David A.
    Kirker, Andrew W.
    Merkur, Andrew B.
    Etminan, Mahyar
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (05) : 390 - 393